MIR3200

Across TCGA pan-cancer cohorts, MIR3200 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR3200 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3200 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3200 expression acts as an unfavorable survival marker, although some lineages such as ACC and SKCM show a favorable association.

MESO, KIRP, and LIHC are the cancer types where MIR3200 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.036	0.602	<.001	90	view →
KIRP	OS	Tertile	All	0.659	0.915	<.001	63	view →
LIHC	OS	Tertile	All	0.051	0.775	<.001	54	view →
LUAD	DFS	Tertile	II,III,IV	0.161	0.659	<.001	45	view →
GBM	OS	Tertile	All	0.217	0.434	.003	27	view →
BRCA	DFS	Tertile	II,III,IV	0.825	0.945	<.001	24	view →
KICH	OS	Tertile	All	0.248	0.923	.019	21	view →
KIRC	DFS	Tertile	IV	0.194	0.623	<.001	18	view →
DLBC	DFS	Tertile	All	0.373	0.835	.009	18	view →
UCEC	OS	Tertile	All	0.798	0.879	.027	18	view →
ACC	DFS	Tertile	III,IV	1.000	0.146	.028	15	view →
CESC	DFS	Tertile	All	0.596	0.755	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR3200–MESO (OS)

Open the MESO breakdown →